Cipla share price is Up ▲ 5% on 26-July-2024. | 4.69m shares traded.
Its Current Matket Price is Rs 1575 and Market Cap is approximately : 1.3 Lack Crores.
The stock is up ▲ 4.5% in 7 days,
up ▲ 6.5% in 1 month
and up ▲ 6.5% in 2 months.
Please click image for Latest Daily data.
Cipla Results Mar 2024 (Standalone_YoY) revenue elevated to 4037 crores up 3% in Mar 2024 quarter, compared with 3894 crores in Mar 2023. Its Net profit is 1038 crores up 192% in Mar 2024 quarter, compared with 355 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.
Click Image for Data | Scroll down for Comments
About Cipla :
Founded: 1935, Mumbai
Founder: Khwaja Abdul Hamied
Headquarters: Mumbai
Number of employees: 32,323 (2023)
Revenue: 22,753 crores INR (US$2.8 billion, FY23)
Subsidiaries: Cipla USA Inc., Cipla (EU) Limited,
Cipla Limited is an Indian pharmaceutical company that was founded in 1935 in Mumbai. It is the third largest drug producer in India and has 47 manufacturing locations globally. Cipla’s products include:
Active pharmaceutical ingredients
Pharmaceutical and personal care products
Antiretroviral drugs
Escitalopram oxalate
Lamivudine
Fluticasone propionate
Cipla’s products are used to treat a variety of medical conditions, including: Respiratory disease, Cardiovascular disease, Arthritis, Diabetes, Depression.
Cipla subsidiaries include Cipla USA Inc. and Cipla Kenya Limited.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-
Please visit
To find any stock of Indian stock market, with every day % .
Only Data. Not Buy or Sell advice.
Please share to reach more people.